Wedbush cuts Xenon Pharmaceuticals price target to $55
Wedbush lowered its price target on Xenon Pharmaceuticals to $55.00 from $71.00, according to ratings actions cited.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.